Background Health conditions, immune dysfunction, and premature aging associated with
trisomy 21 (Down syndrome, DS) may impact the clinical course of COVID-19. Methods The …

Adults with Down Syndrome (DS) are at higher risk for severe outcomes of coronavirus
disease 2019 (COVID-19) than the general population, but evidence is required to understand …

Individuals with Down syndrome (DS) are among the groups with the highest risk for severe
COVID-19. Better understanding of the efficacy and risks of COVID-19 vaccines for …

Pneumonia and respiratory infections impact infants and children with Down syndrome;
pneumonia is a leading cause of mortality in adults with Down syndrome. We aimed to review …

Background: Collectively, people with Down syndrome (DS) are one of the highest risk groups
for mortality associated with COVID-19, but outcomes may differ across countries due to …

Adults with Down syndrome (DS) represent a unique population who are in need of clinical
guidelines to address their medical care. The United States Preventive Service Task Force (…

Importance Down syndrome is the most common chromosomal condition, and average life
expectancy has increased substantially, from 25 years in 1983 to 60 years in 2020. Despite …

… Dr Chicoine receives royalties for books that he coauthored, published by Woodbine House.
Dr Majekodunmi has received speaker fees from Medtronic, GE Healthcare, and Sanofi. Dr …

Purpose Given the current life expectancy and number of individuals living with Down
syndrome (DS), it is important to learn common occurrences of disease conditions across the …

Importance Adults with Down syndrome (DS) are at higher risk for severe outcomes of
coronavirus disease 2019 (COVID-19), but further evidence is required to determine the exact …